Summary - A new market study, titled “Global Influenza Market By Product Type (Vaxigrip, Influvac)-Forecast 2020”has been featured on WiseGuy Reports.
The Indian Influenza market has reported a remarkable growth in recent years, and is presenting ample opportunities to the industry’s players. With increasing pandemic as well as seasonal outbreak and rising awareness among people about these vaccines, the Indian influenza vaccine market is poised to scale newer acmes. Moreover, increasing disposable income, increasing incidences of influenza, introduction of new vaccines, entry of new players, and rising R&D investments are set to further boost the market’s growth. Owing to such factors, the Indian influenza market is anticipated to grow at a healthy CAGR during the forecast period (2015-2020).
In the report “IIndian Influenza Market By Product Type (Vaxigrip, Influvac)-Forecast 2020”, RNCOS analysts have endeavoured to address the current scenario of Indian influenza industry, factors favouring growth of the market, and the major roadblocks restraining the influenza vaccines market. Additionally, the report includes the study of opportunities, which are available in the Indian influenza market.
Furthermore, the report covers detailed description of the current scenario of the Indian influenza vaccine market, and its future forecast till 2020. Indian Influenza Vaccines market is analyzed in both volumes in doses, and value in US$ for the period from 2015 through to 2020. The report also provides detailed bifurcation of Indian influenza market on the basis of product type, such as Vaxigrip, Influvac, and others. The report also provides the potential market for influenza vaccines. Moreover, the report highlights the mergers and acquisitions that have taken place in the Indian influenza market. Pricing analysis along with the regulatory scenario governing the Indian influenza market has also been mentioned in the report. Furthermore, the report provides the details about the distribution channel for influenza vaccines in the Indian industry.
The latter half of the report provides competitive landscape including the market share of key players, such as Cipla Ltd., Bharat Biotech, Serum Institute of India, Abbott, Lupin Ltd, and others. A brief business overview and financial information about each of these players has been provided in the report, along with the company overviews and financial revenues of the key participants to develop their positions in the global market. The recent development and strength-weakness analysis of every player has also been presented to assist the investors in developing an understanding of the strategies of major players. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the Indian Influenza market.
FOR MORE DETAILS: https://www.wiseguyreports.com/reports/1706501-indian-influenza-market-by-product-type-vaxigrip-influvac-forecast-2020
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +162-825-80070 (US)
Ph: +44 203 500 2763 (UK)
A new market intelligence report released by DPI Research with the title “Global Influenza Vaccines Market 2021 – 2027” is designed to cover micro-level analysis by manufacturers and key business segments.
The Global Influenza Market analysis offers active visions to conclude and study the market size, trends, growth, demand, revenue, market share by company, and competitive backgrounds.
This report also provides SWOT Analysis with potential market opportunities for assessing the Overall Market, underlining opportunities, and supporting strategic and tactical decision-making for companies and individuals.
Some of the key players profiled in the study are Sanofi Pasteur, GlaxoSmithKline (GSK), Seqirus (CSL Limited), AstraZeneca, Mylan, BioDiem, Novavax, Medicago, Moderna Inc, Pneumagen, Daiichi–Sankyo, Altimmune, FluGen, Imutex, EpiVax, Versatope Therapeutics, Inc., Gamma Vaccines Pty Ltd., BiondVax Pharmaceuticals Ltd., Hualan Biological Engineering Inc., Shanghai Institute of Biological Products Co., Ltd. Get Download Exclusive PDF Sample Copy of this Report to understand the structure of the complete Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://dpiresearch.com/request-a-free-sample-report/ DPI Research analysts predict: The number of persons being vaccinated with influenza vaccines worldwide will touch the figure of 500 Million by the year-end of 2027.Market growth can be attributed to factors such as increased disease awareness, expanded recommendations by governmental and advisory bodies to be vaccinated against influenza vaccines, the introduction of quadrivalent influenza vaccines, increase in the size of the elderly population in most of the countries.Long–term Growth Projection:The global influenza vaccines market size is set to surpass US$ 6.5 Billion by the year-end of 2021Influenza vaccines demand is expected to increase in the forecast periodThe United States influenza vaccines market is projected to grow with a significant CAGR in the forecast periodIn Japan, the influenza vaccines market holds a rewarding growth opportunity for the future as the demand for the vaccine is growing significantlyThe Chinese influenza vaccines market is expected to record a value of nearly US$ 180 Million by the year-end of 2027Europe is anticipated to be the fastest-growing market during the forecast periodThe United Kingdom and Germany are the leading revenue generators of the marketEmerging players backed by technological advancements are developing vaccines that offer a more realistic experienceKnow more details about Global Vaccine Market click here @ https://dpiresearch.com/reports/global-influenza-vaccines-market-analysis/ Key Features of the Study:The Market Size of the Global Influenza Vaccines Market with Six Years ForecastThe Market Size of the Regional and National Influenza Vaccines Market with Six Years ForecastScrutinizes the Global Overall Persons Being Vaccinated with Influenza VaccinesScrutinizes the Regional and National Persons Being Vaccinated with Influenza VaccinesDelivers a Latest Happenings in the Global Influenza Vaccines MarketDetailed Insights of the Regulatory Framework Including the Approval Process and an Overview of the Regulatory Authorities in the United States, EU, and JapanProvides Key Trends with Respect to Collaboration Deals, Merger & Acquisitions, Distribution, Exclusive and Licensing AgreementReviews Most Recent Clinical Trials of the Influenza VaccinesA Comprehensive List of the Key Players Along with the Analysis of their Current Vaccines Portfolios, Promising Vaccines in the Clinical Development, Sales Value Analysis, and Recent DevelopmentAn Insightful Analysis of the Emerging Players Along with the Analysis of their Promising Vaccines in the Clinical Development, Phase, Platform Technology, and Recent Development The Report Analyses the Market Based on Countries and Presents the Forecast in Terms of Value and Volume for the Next Six Years.
Twenty-One Major Markets(21MM) Covered in the Report are as follows: United StatesCanadaBrazilGermanyFranceItalySpainUnited KingdomNetherlandsSwedenDenmarkPolandNorwayFinlandIrelandBelgiumAustraliaNew ZealandJapanChinaIndia The Report Provides a Comprehensive Analysis of Company Profiles Listed Below: Sanofi PasteurGlaxoSmithKline (GSK)Seqirus (CSL Limited)AstraZenecaMylanBioDiemNovavaxMedicagoModerna IncPneumagenDaiichi–SankyoAltimmuneFluGenImutexEpiVaxVersatope Therapeutics, Inc.Gamma Vaccines Pty Ltd.BiondVax Pharmaceuticals Ltd.Hualan Biological Engineering Inc.Shanghai Institute of Biological Products Co., Ltd.
How much will this market be worth from 2020 to 2027?How many persons being vaccinated with influenza vaccines globally during 2015 – 2027?Which country is expected to hold the highest market share in the global influenza vaccine market?What are the main drivers and restraints in the global influenza vaccines market?What are the major deals happenings in the global influenza vaccines market?Who are the top players and what are their activities, revenue, recent developments, and prospects?What are some of the most prominent influenza vaccines currently in development?
The Business Research Company published its Influenza Diagnostic Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global Influenza Diagnostic market.
The report provides in-depth analysis of the impact of COVID-19 on the market, along with revised market numbers due to the effects of the coronavirus.The report covers the influenza diagnostic market’s segments- 1) By Traditional Diagnostic Tests: Rapid Influenza Diagnostic Tests (RIDT), Viral Culture, DFA, Serological Assays, Others2) By Molecular Diagnostic Tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests3) By End User: Hospitals & Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users.View Complete Report: https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-market-global-report-2020-30-covid-19-implications-and-growthInfluenza Diagnostic Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market.
The chapter also covers markets which have been positively affected by the pandemic.The global influenza diagnostics market is expected to grow from $1.14 billion in 2019 to 1.31 billion in 2020 at a compound annual growth rate (CAGR) of 14.7%.
This is expected to drive the demand for more rapid detection diagnostic kits.
For instance, the CDC is seeking emergency use authorization from the FDA for a new assay that can simultaneously detect SARS-CoV-2 and influenza.
